Vistim Labs
PrivateLast Round
Seed
May 11, 2023
Total Funding Raised
$800,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vistim Labs is a medical technology company that develops AI-powered neurodiagnostic software and brain-mapping tools for the monitoring and evaluation of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vistim Labs Comparables
Compare Vistim Labs with similar companies based on industry and business-model similarity.
Vistim Labs Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Vistim Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GoAhead Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Grew 29% QoQ from 14 to 18 employees.
- Jul 26, 2026
Monthly visitors grew 1600% MoM, reaching 1.3K.
Vistim Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vistim Labs's valuation, stock price, and market status.
Is Vistim Labs a public or private company?
Vistim Labs is a private company.
What is the current stock price of Vistim Labs?
Vistim Labs is a private company, so its shares have no public market price. Caplight tracks Vistim Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vistim Labs worth (valuation)?
Valuation information for Vistim Labs is not publicly available.
Can I buy Vistim Labs stock?
Vistim Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vistim Labs's last funding round?
Vistim Labs's most recent funding round was Seed on May 11, 2023.
Who are the main investors in Vistim Labs?
Key investors in Vistim Labs include GoAhead Ventures.
Will Vistim Labs IPO soon?
No public IPO plans have been announced for Vistim Labs.
How can I track Vistim Labs secondary market activity?
Caplight tracks bids, offers, and trades in Vistim Labs's shares on secondary markets.